Official Statistics

Anti-nucleocapsid (N) antibodies against COVID-19 (SARS-CoV-2) population estimates: March 2021 to January 2022

Exploratory modelled percentage of the population with levels of Anti-Nucleocapsid (N) antibodies against SARS-CoV-2 at or above 20 nanograms per millilitre (ng/ml) or 30 ng/ml, using data from the coronavirus (COVID-19) infection survey, by age group, UK countries.

Documents

Anti-nucleocapsid (N) antibodies against COVID-19 (SARS-CoV-2) population estimates: March 2021 to January 2022

Details

Official statistics are produced impartially and free from political influence.

Updates to this page

Published 20 January 2023

Sign up for emails or print this page